Der Markt für molekulare Qualitätskontrollen wird im Jahr 2028 voraussichtlich 372,64 Millionen US-Dollar erreichen, gegenüber 184,62 Millionen US-Dollar im Jahr 2021; Es wird geschätzt, dass es im Zeitraum 20212028 mit einer jährlichen Wachstumsrate von 10,6 % wachsen wird.
Molekulare Qualitätskontrollen helfen, die Leistung von Testverfahren zu überwachen. Diese Tests sind hilfreich, um wichtige und genaue Diagnoseinformationen zu erhalten. Diese Kontrollen werden auch zur Bestimmung übertragbarer und genetisch bedingter Krankheiten eingesetzt. Darüber hinaus tragen die molekularen Qualitätskontrollen auch dazu bei, die Leistung von Nukleinsäuretestprotokollen für gesundheitsbezogene Infektionen, Viruslasttests und sexuell übertragbare Infektionen zu überwachen. Das Wachstum des Marktes für molekulare Qualitätskontrollen wird auf Faktoren wie wachsende Mittel für die Genomik, sinkende Kosten für Sequenzierungsverfahren und die zunehmende Prävalenz genetischer Krankheiten zurückgeführt, die das Wachstum des Marktes befeuern. Allerdings behindert der Mangel an Fachkräften das Marktwachstum.
Lukrative Regionen für den Markt für molekulare Qualitätskontrollen
Markteinblicke
Steigende Prävalenz genetischer Krankheiten
Molekulare Qualitätskontrollen werden zur Erkennung genetischer Krankheiten eingesetzt, da diese bei der Interpretation der Ergebnisse helfen. Das Down-Syndrom ist eine genetische Störung, die durch eine abnormale Zellteilung verursacht wird, die zu einer zusätzlichen vollständigen oder teilweisen Kopie des Chromosoms 21 führt. Nach Angaben der US-amerikanischen Zentren für die Kontrolle und Prävention von Krankheiten (CDC) werden in den USA jedes Jahr etwa 6.000 Neugeborene geboren leiden unter dem Down-Syndrom. Infolgedessen nehmen im Land vorgeburtliche Tests auf das Down-Syndrom zu.
Die meisten erblichen Fälle von Brustkrebs sind mit Mutationen in zwei Genen verbunden: BRCA1 (BReast CAncer-Gen eins) und BRCA2 (BReast CAncer-Gen zwei). Nach Angaben der American Cancer Society sind etwa 5 bis 10 % der Brustkrebsfälle erblich bedingt, da mutierte Gene von den Eltern auf die Kinder übertragen werden. Das wachsende Bewusstsein für Brustkrebs erhöht die Akzeptanz von Gentests für erblich bedingten Brustkrebs.
Darüber hinaus ist die Sichelzellenanämie (SCD) laut CDC eine häufige genetische Bluterkrankung in den USA, von der etwa 70.000 bis 100.000 Amerikaner betroffen sind. Darüber hinaus sind laut WHO 5 % der Weltbevölkerung Träger der Gene für Hämoglobinerkrankungen wie Sichelzellenanämie und Thalassämie. Daher steigert die zunehmende Prävalenz solcher genetischer Erkrankungen die Nachfrage nach molekularen Qualitätskontrollen.
Produktbasierte Erkenntnisse
Basierend auf dem Produkt ist der Markt für molekulare Qualitätskontrollen in unabhängige Kontrollen und segmentiert instrumentenspezifische Bedienelemente. Das Segment der unabhängigen Kontrollen hielt im Jahr 2020 einen größeren Marktanteil, während dieses im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen wird.
Markt für molekulare Qualitätskontrollen, nach Produkt 2020 und 2028
Analytentypbasierte Erkenntnisse
Basierend auf dem Analyttyp ist der Markt für molekulare Qualitätskontrollen in Einzelanalytkontrollen und Multianalytkontrollen unterteilt. Das Segment der Einzelanalyt-Kontrollen hielt im Jahr 2021 einen größeren Marktanteil, während das Segment der Multi-Analyt-Kontrollen im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen wird.
Anwendungsbasierte Erkenntnisse
Basierend auf der Anwendung ist der Markt für molekulare Qualitätskontrolle in Infektionskrankheiten, Onkologie, Gentests und andere Anwendungen unterteilt. Das Segment Infektionskrankheiten hatte im Jahr 2021 den größten Marktanteil, während das Segment Onkologie im Prognosezeitraum voraussichtlich die höchste CAGR im Markt verzeichnen wird.
Vertriebskanalbasierte Einblicke
< p>Basierend auf dem Endbenutzer ist der Markt für molekulare Qualitätskontrolle in klinische Labore, Krankenhäuser, IVD-Hersteller und Auftragsforschungsorganisationen, akademische und Forschungsinstitute sowie andere Endbenutzer unterteilt. Das Segment Klinische Laboratorien hatte im Jahr 2021 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR des Marktes verzeichnen.
Strategische Einblicke
Produkteinführungen und -zulassungen sind die gängigsten Strategien von Unternehmen, um ihre globale Präsenz und ihr Produktportfolio zu erweitern. Darüber hinaus konzentrieren sich die Marktteilnehmer für molekulare Qualitätskontrollen auf die Kooperationsstrategie, um ihren Kundenkreis zu vergrößern, was ihnen wiederum ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.
Markt für molekulare Qualitätskontrollen nach Produkt
- Unabhängige Kontrollen
- Instrumentenspezifische Kontrollen
Markt für molekulare Qualitätskontrollen nach Analyttyp
- Einzelanalytische Kontrollen
- Multianalyt-Kontrollen
Markt für molekulare Qualitätskontrollen nach Anwendung
- Infektionskrankheiten
- Onkologie
- Gentests
- Andere Anwendungen
Markt für molekulare Qualitätskontrollen nach Endbenutzer
- Klinische Laboratorien
- Krankenhäuser
- IVD-Hersteller und Auftragsforschungsinstitute
- Akademische und Forschungsinstitute
- Andere Endbenutzer
Markt für molekulare Qualitätskontrollen nach Geografie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien
- Spanien
- Übriges Europa
- Asien-Pazifik (APAC)
- China
- Indien
- Süden Korea
- Japan
- Australien
- Übriger Asien-Pazifik-Raum
- Naher Osten und Afrika (MEA)
- Südafrika
- Saudi-Arabien
- VAE
- Übriger Naher Osten und Afrika
- Süd- und Mittelamerika (SCAM)
- Brasilien
- Argentinien
- Übriges Süd- und Mittelamerika
Unternehmensprofile
- THERMO FISHER SCIENTIFIC, INC.
- BIO-RAD LABORATORIES, INC.
- F. HOFFMANN LA-ROCHE LTD.
- Abbott
- Quidel Corporation
- Qnostics
- Maine Molecular Controls, Inc.
- Zeptometrix Corporation
- Microbiologics
- Seracare Life Sciences
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Molecular quality controls help to monitor the performance of testing procedures. These tests are helpful to achieve critical and accurate diagnostic information. These controls are used to determine transmissible and genetic diseases too. Moreover, the molecular quality controls also help to monitor the performance of nucleic acid testing protocols for healthcare associated infections, viral load assays and sexually transmitted infections.
The global molecular quality controls market growth is mainly attributed to factors such growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. Moreover, rising adoption of molecular diagnostics is likely to create growth opportunities for the market
The molecular quality controls market majorly consists of the players such as Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann La-Roche Ltd, Abbott, Quidel Corporation, Qnostics, Maine Molecular Controls, Inc., Zeptometrix Corporation, Microbiologics, and Seracare Life Sciences among others.
The List of Companies - Molecular Quality Controls Market
- TOHERMO FISHER SCIENTIFIC, INC.
- BI-RAD LABORATORIES, INC.
- F. HOFFMANN LA-ROCHE LTD.
- Abbott
- Quidel Corporation
- Qnostics
- Maine Molecular Controls, Inc.
- Zeptometrix Corporation
- Microbiologics
- Seracare Life Sciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)